Vriglib-M Tablet SR
Prescription Required
Introduction of Vriglib-M Tablet SR
Vriglib-M Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Vriglib-M Tablet SR is used in the treatment of type 2 diabetes mellitus . It is a combination medicine that can control blood sugar better than single medication. It should be used along with a proper diet and regular exercise for best results. Hypoglycemia (low blood sugar level) may occur as a side effect and it should be taken with food to avoid upset stomach.
Vriglib-M Tablet SR is used in the treatment of type 2 diabetes mellitus . It is a combination medicine that can control blood sugar better than single medication. It should be used along with a proper diet and regular exercise for best results. Hypoglycemia (low blood sugar level) may occur as a side effect and it should be taken with food to avoid upset stomach.
Uses of Vriglib-M Tablet SR
Benefits of Vriglib-M Tablet SR
In Treatment of Type 2 diabetes mellitus
Vriglib-M Tablet SR is a medicine that helps to control high blood glucose (sugar) levels. It helps get rid of extra glucose from your body through urine. It also improves the body’s response to the hormone insulin, which is responsible for regulating blood glucose (sugar) levels in our body. The insulin helps to lower your blood glucose levels and prevents them from rising after taking meals. You should keep taking it for as long as it is prescribed.
Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life.
Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life.
Side effects of Vriglib-M Tablet SR
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Vriglib-M
- Nausea
- Vomiting
- Diarrhea
- Flatulence
How to use Vriglib-M Tablet SR
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Vriglib-M Tablet SR is to be taken with food.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Vriglib-M Tablet SR.
Pregnancy
SAFE IF PRESCRIBED
Vriglib-M Tablet SR is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding
CAUTION
Vriglib-M Tablet SR should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Driving
CONSULT YOUR DOCTOR
It is not known whether Vriglib-M Tablet SR alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
UNSAFE
Vriglib-M Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor.
Liver
CAUTION
Vriglib-M Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Vriglib-M Tablet SR may be needed. Please consult your doctor.
Vriglib-M Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Vriglib-M Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
What if you forget to take Vriglib-M Tablet SR?
If you miss a dose of Vriglib-M Tablet SR, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Vriglib-M Tablet SR
₹10.9/Tablet SR
Diabetrol SR Tablet
Abbott
₹7.57/tablet sr
27% cheaper
Glutowin Forte Tablet SR
Micro Labs Ltd
₹5/tablet sr
52% cheaper
Daonil-M Tablet SR
Emcure Pharmaceuticals Ltd
₹5.56/tablet sr
47% cheaper
Glucored Forte SR Tablet
Sun Pharmaceutical Industries Ltd
₹2.55/tablet sr
75% cheaper
Duotrol-SR Tablet
USV Ltd
₹4.87/tablet sr
53% cheaper
Quick tips
Vriglib-M Tablet SR
- You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines along with Vriglib-M Tablet SR.
- Take it with food to lower your chance of having an upset stomach.
- It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
- Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic.
- Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea, vomiting, and stomach pain as Vriglib-M Tablet SR may cause a rare but serious condition called lactic acidosis, which is an excess of lactic acid in the blood.
- Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Fact Box
Habit Forming
No
Therapeutic Class
ANTI DIABETIC
Patient concerns
Patient concerns
FAQs
Vriglib-M Tablet SR
Q. What is Vriglib-M Tablet SR?
Vriglib-M Tablet SR is a combination of two medicines: Glibenclamide and Metformin. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves the blood glucose levels in adults when taken along with proper diet and regular exercise. Glibenclamide lowers the blood glucose levels by increasing the release of insulin from the pancreas. Metformin works by lowering the glucose production in the liver and improving insulin sensitivity. This combination is not indicated for the treatment of Type 1 DM.
Q. What is type 2 diabetes?
Type 2 diabetes is the most common form of diabetes. It is a condition in which the body is unable to make enough insulin, and the insulin produced by the body does not work well. When this happens, the glucose level in the blood rises and leads to serious medical problems. Symptoms of high blood sugar include frequent urination, increased thirst and increased hunger. Diabetes, if not treated properly, can cause long-term complications like neuropathy (nerve damage), nephropathy (kidney damage), eye damage (retinopathy), foot problems and also a higher risk of developing heart diseases.
Q. What are the possible side effects of Vriglib-M Tablet SR?
The use of Vriglib-M Tablet SR is associated with common side effects like hypoglycemia (low blood sugar level), altered taste, nausea, stomach pain, diarrhea, headache and upper respiratory tract infection. Its use can also lead to serious but rare side effects like lactic acidosis. On long-term use, it can also lead to vitamin B12 deficiency.
Q. Can the use of Vriglib-M Tablet SR cause hypoglycemia?
Yes, the use of Vriglib-M Tablet SR can cause hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate and feeling anxious or shaky. It happens more often if you miss or delay your food, drink alcohol, over-exercise or take other antidiabetic medicine along with this medicine. So, regular monitoring of blood sugar level is important. Always keep a quick source of sugar like glucose tablets, honey or fruit juice with you.
Q. Can the use of Vriglib-M Tablet SR lead to Vitamin B12 deficiency?
Yes, the use of Vriglib-M Tablet SR can cause vitamin B12 deficiency on long-term use as it interferes with the absorption of vitamin B12 in the stomach. If untreated, it may cause anemia and nerve problems and the patient may feel a tingling sensation and numbness in hands and feet, weakness, urinary problems, change in mental status and difficulty in maintaining balance (ataxia). To avoid such problems, some researchers suggest an intake of Vitamin B12 from outside sources at least once every year.
Q. Are there any specific conditions in which Vriglib-M Tablet SR should not to be taken?
The use of Vriglib-M Tablet SR should be avoided in patients with known allergy to any of the components or excipients of this medicine. It should also be avoided in patients with moderate to severe kidney disease and in patients with underlying metabolic acidosis including diabetic ketoacidosis.
Q. Is it safe to take alcohol while I am also taking Vriglib-M Tablet SR?
No, it is not safe to take Vriglib-M Tablet SR along with alcohol, as it may lower your low blood sugar levels (hypoglycemia) and can increase the chances of lactic acidosis.
Q. What are the instructions for storage and disposal of Vriglib-M Tablet SR?
Keep this medicine in the container or the pack it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Glyburide and Metformin HCl Tablets [FDA Prescribing information]. Princeton, NJ: Bristol-Myers Squibb Company; 2013. [Accessed 28 Oct. 2021] (online) Available from:
- Glyburide and Metformin HCl. Princeton, New Jersey: Bristol-Myers Squibb Company; 2009. [Accessed 08 Apr. 2019] (online) Available from:
Marketer details
Name: Vridam Healthcare Pvt Ltd
Address: Plot No-3, Sr. No. 323, 2B, Dnyaneshwar Nagar, Pathardi Phata, Nashik, Maharashtra 422009, Mobile No. 9970325741
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹109
Inclusive of all taxes
10.0 tablet sr in 1 strip
SOLD OUT
Notify me